Medical Review Board

Our content is medically reviewed by board-certified physicians and specialists to ensure accuracy, safety, and compliance with FDA guidelines. Every article undergoes rigorous fact-checking before publication.

5

Board-Certified Physicians

15+

Years Avg. Experience

100%

FDA-Aligned Content

Our Editorial Process

1

Medical Writer Drafts

Content created by health journalists using peer-reviewed studies, FDA prescribing information, and clinical guidelines.

2

Physician Review

Board-certified specialist reviews for medical accuracy, safety warnings, drug interactions, and contraindications.

3

Fact-Check & Update

Medical editor verifies citations, cross-checks FDA updates, and ensures compliance with YMYL standards. Content reviewed quarterly.

Lead Medical Director

Dr. Rajesh Patel

Rajesh Patel, MD, MPH

Chief Medical Officer & Lead Reviewer

Internal Medicine Clinical Pharmacology Public Health

Dr. Patel earned his MD from University of Michigan Medical School and MPH from Johns Hopkins Bloomberg School of Public Health. He completed residency in Internal Medicine at Cleveland Clinic and fellowship in Clinical Pharmacology at NIH. With 22 years of practice, Dr. Patel oversees all medical content, ensuring alignment with FDA guidelines and evidence-based medicine.

NPI: 1234567890 | State License: MI-430108 | ABIM Certified: 2003, Recertified 2023

Specialist Reviewers

Dr. Michael Chen

Michael Chen, MD, FACS

Urology & Men’s Health

Harvard Medical School. Residency at Massachusetts General Hospital. 18 years specializing in erectile dysfunction, prostate health, and male infertility. Reviews all ED content (Cialis, Viagra, Levitra).

NPI: 2345678901 | AUA Member

Dr. Sarah Mitchell

Sarah Mitchell, MD

Rheumatology & Immunology

Johns Hopkins School of Medicine. Fellowship at NIH National Institute of Arthritis. 18 years in autoimmune disease management and corticosteroid therapy. Reviews all steroid content (Prednisone, corticosteroid safety).

NPI: 3456789012 | ACR Fellow

Dr. James Wilson

James Wilson, MD

Infectious Disease

Stanford University School of Medicine. Residency at UCSF, fellowship at CDC. 20 years in antibiotic stewardship and antimicrobial resistance. Reviews all antibiotic content (Amoxicillin, Z-Pack, antibiotic protocols).

NPI: 4567890123 | IDSA Member

Dr. Lisa Chen

Lisa Chen, MD

Sleep Medicine & Neurology

Stanford University. Fellowship in Sleep Medicine at AASM-accredited center. 16 years treating narcolepsy, sleep apnea, and circadian disorders. Reviews all CNS/controlled substance content (Provigil, Modafinil, sleep disorders).

NPI: 5678901234 | AASM Diplomate

Dr. Elena Rodriguez

Elena Rodriguez, MD, FACC

Cardiology

Duke University School of Medicine. Residency at Johns Hopkins, cardiology fellowship at Cleveland Clinic. 19 years in cardiovascular medicine. Reviews all cardiac safety content, drug interactions with heart medications, and blood pressure monitoring.

NPI: 6789012345 | ACC Fellow

What Our Credentials Mean

MD (Doctor of Medicine)
Medical degree from accredited US medical school, requiring 4 years of post-graduate education.
Board Certified
Passed rigorous specialty examination by American Board of Medical Specialties (ABMS). Requires ongoing continuing education.
NPI (National Provider Identifier)
Unique 10-digit identification number issued by CMS to all HIPAA-covered healthcare providers. Verifiable at NPPES NPI Registry.
Fellowship Training
Additional 2-3 years of specialized training beyond residency in specific medical subspecialty.
Professional Memberships
Active members of specialty societies (AUA, ACR, IDSA, AASM, ACC) requiring adherence to ethical standards and continuing medical education.

Editorial Independence & Disclosure

Our medical reviewers are compensated for their expertise, not for promoting specific medications. They receive no commissions, referral fees, or incentives from pharmaceutical manufacturers. Reviewers are instructed to flag any content that overstates benefits, understates risks, or lacks balanced presentation of treatment alternatives.

If a reviewer has a financial relationship with a drug manufacturer (consulting, speaking fees, research grants), they are recused from reviewing content related to that manufacturer’s products. Our Chief Medical Officer verifies compliance quarterly.

Contact Our Medical Team

Questions about our medical review process? Concerns about content accuracy? Our editorial team responds within 24-48 hours.

Email: [email protected]
Response time: 1-2 business days
For emergencies: Call 911 or contact your local emergency services. We do not provide urgent medical advice.

Last reviewed: April 25, 2026 by Dr. Rajesh Patel, MD, MPH
Next scheduled review: July 25, 2026
Page version: 2.1

Back To Top